Gastroenterology CME

  • 25% OFF W/ CODE: CME25
    FEATURED

    Johns Hopkins Review of Medical and Surgical Gastroenterology

    Continuing Medical Education: Advances in Gastroenterology

    In the Johns Hopkins Review of Medical and Surgical Gastroenterology online CME course, leading experts discuss diagnosis and treatment of gastrointestinal and liver disease.

    After completing this board review, you’ll be better able to:

    • Identify and scrutinize the best approach to the management of hepatobiliary disorder
    • Describe updates and paradigm changes in the treatment of various liver diseases
    • Outline the medical and surgical approaches to esophageal and gastric disease
    • Identify and utilize the latest therapeutic modalities to the management of inflammatory bowel disease
    • Analyze and review the various GI conditions that may affect a pregnant patient
    • Assess the various options for bariatric surgery and delineate diagnosis algorithms for GI bleeding

    Learning Objectives

    At the conclusion of this activity, the participant will be able to:

    • Identify and scrutinize the best approach to the management of hepatobiliary disorders
    • Describe updates and paradigm changes in the treatment of various liver diseases
    • Outline the medical and surgical approaches to esophageal and gastric disease
    • Identify and utilize the latest therapeutic modalities to the management of inflammatory bowel disease
    • Analyze and review the various GI conditions that may affect a pregnant patient
    • Assess the various options for bariatric surgery and delineate diagnosis algorithms for GI bleeding

    Intended Audience

    This activity is intended for gastroenterologists, surgeons, internists, family practitioners, physician assistants, nurse practitioners, nurses and other allied health professionals.

    See full details chevron_right
    • Cost: $695
    • Credit hours: 12.25
    • CME credits awarded by: Oakstone Publishing, LLC
    • Format: On-Demand Online, Online Video, Online Audio, Audio CD
    • Material last updated: April 13, 2018
    • Expiration of CME credit: April 13, 2021
  • 25% OFF W/ CODE: CME25
    FEATURED

    The Brigham Board Review in Gastroenterology and Hepatology

    Earn CME Credits and Board Review Prep

    The Brigham Board Review in Gastroenterology and Hepatology provides in-depth CME coverage of wide-ranging topics, keeping you abreast of the latest advances in the field.

    This board review course includes case-based lectures on topics like GERD, gastrointestinal bleeding, gastric and small bowel motility disorders, acute liver failure, celiac disease, benign and malignant biliary diseases, and more. It’s online CME that will help you to better:

    • Apply latest/recommended gastroenterology guidelines in clinical practice
    • Attain the latest knowledge on clinical presentation, pathologic features, diagnosis, and differential diagnosis of various gastroenterology disorders
    • Stay updated on an expanding array of therapeutic options for diverse gastrohepatic disorders
    • Evaluate and interpret up-to-date literature for evidence-based clinical practice in gastroenterology
    • Prepare for ABIM certification/recertification gastroenterology examinations

    Learning Objectives

    At the conclusion of this activity, the participant will be able to:

    • Apply current/recommended gastroenterology guidelines in clinical practice
    • Perform differential diagnosis of complex clinical presentations related to gastroenterology disorders
    • Identify and apply current therapeutic options for specific gastroenterology disorders
    • Analyze and interpret up-to-date literature relevant to clinical practice in gastroenterology
    • Recognize and apply knowledge of pathophysiology as it applies to management of gastroenterology disorders
    • Apply knowledge gained to the ABIM certification/recertification gastroenterology examinations

    Intended Audience

    This educational activity was designed for fellows/trainees and practicing gastroenterology specialists (MDs) and other professional affiliates (internists with an interest in gastroenterology) who are preparing to take ABIM Board Review or Recertification Examinations or who seek CME activities to improve patient care in the area of gastroenterology medicine. The target audience is regional, national and international.

    See full details chevron_right
    • Cost: $995
    • Credit hours: 33
    • CME credits awarded by: Oakstone Publishing LLC
    • Format: On-Demand Online, Online Video, Online Audio, Audio CD
    • Material last updated: July 15, 2018
    • Expiration of CME credit: July 15, 2021
  • FREE

    CME: Metastatic colorectal cancer (mCRC) treatment: Therapeutic updates, best practices, and barriers to care

    Colorectal cancer (CRC) is the third-leading cause of cancer deaths in the U.S. While a majority of patients are diagnosed before their disease has metastasized, a fifth of patients have advanced disease at the time of diagnosis. Early detection and screening have been shown to significantly reduce CRC mortality, and screening is widely recommended for average-risk adults beginning at age 50 years, (as well as earlier for individuals at higher risk). Since the mid-1990s, the U.S. Preventive Services Task Force, American Cancer Society, and other groups have recommended several modalities for screening: fecal occult blood testing (FOBT), flexible sigmoidoscopy, colonoscopy, and barium enema. Recent years have seen the addition of newer screening technologies, including stool DNA, computed tomographic colonography, and capsule endoscopy.

    Target Audience:

    Healthcare professionals including: medical oncologists, primary care physicians, pathologists, gastroenterologists, and managed care medical care directors; physicians assistants, nurse practitioners, nurses, and pharmacists specializing in oncology; and other clinicians who are involved in providing diagnostic and therapeutic services for patients with CRC.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 2/3/2021
    • Expiration of CME credit: 2/3/2023
  • FREE

    CME: Ulcerative Colitis: Updates from the DDW 2019 Annual Meeting

    IBD is a broad term that includes many different forms of inflammatory bowel conditions, the most common of which are ulcerative colitis (UC) and Crohn’s disease, the former of which exclusively affects the colon and rectum. Guidelines exist for the treatment of UC, but they are constantly changing to include updated information. Despite the plethora of guidelines available, there are issues surrounding guideline adherence by physicians, patient satisfaction, the quality of treatment and a patient’s QOL. Given the data from multiple studies that physicians are either not aware of updated practice guidelines or are not utilizing them, that this lack of knowledge is affecting patient satisfaction, and that there may be demographically-based barriers to care, educational activities are warranted to keep HCPs abreast of best practices in patients with UC. This activity has been designed to review treatment strategies, emerging therapies, and gaps in care of patients with UC.

    By the end of the session the participant will be able to:

    • Describe long-term outcomes of UC patients with dysplasia who undergo endoscopic resection and surveillance and apply that information to a patient case
    • Describe the effect of endoscopic and histologic remission as treatment targets
    • Describe the risk of biologic therapy use in special populations, such as elderly and surgical patients and apply that information to a patient case
    • Recall emerging data on biologic drug safety and efficacy

    Target Audience:

    Healthcare professionals specializing in: gastroenterology, internal medicine, and those who otherwise commonly care for patients with UC.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 9/23/19
    • Expiration of CME credit: 9/23/21
  • FREE

    CME: Pediatric Crohn’s disease: therapeutic updates and optimizing treatment

    Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that is defined by a transmural process that often occurs in the terminal ileum but may occur in any portion of the GI tract. Although the exact etiology of CD is unknown, a handful of genetic, immunological, and environmental risk factors have been identified. Research suggests that in genetically susceptible patients, there is an impaired immune response to commensal or pathogenic intestinal microbiota that drives mucosal inflammation. The incidence of pediatric CD (pCD) is increasing around the globe, varying between 2.5 to 11.4 per 100,000, with an estimated prevalence of 58 per 100,000. Approximately 25% of patients are diagnosed with IBD before the age of 18. Intestinal and abdominal complications such as strictures, abscesses, and fistulas are common among pediatric patients and increase as the disease progresses. IBD impairs attendance at school, and psychosocial ramifications in children diagnosed with IBD incdude a higher incidence of depression and anxiety.

    By the end of the session the participant will be able to:

    • Describe differences between European and American approaches to pCD
    • Identify the present nutritional and pharmacotherapeutic treatment options currently available for management of pCD and apply them to patient cases using evidence-based medicine
    • Identify new and emerging approaches to and therapies for the treatment of pCD
    • Evaluate a treatment plan for a specific patient based on severity of pCD to optimize safety and efficacy, suggesting modifications for improvement

    Target Audience:

    The following healthcare professionals: pediatricians and pediatric gastroenterologists; physician assistants, nurse practitioners, nurses, and pharmacists; and any other healthcare professionals with an interest in or who clinically encounter patients with pCD.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 5/24/19
    • Expiration of CME credit: 5/24/21
  • Medical Marijuana Certification Course: Massachusetts

    The Medical Marijuana Certification Course will help Massachusetts physicians make informed decisions regarding medicinal cannabis treatments for their patients. This activity provides an evidence based analysis of marijuana’s efficacy, risks and benefits in treating a wide range of state approved conditions. The science, safety and impact of medical marijuana will be explored, in order to enhance physician knowledge of this emerging healthcare resource. Worth 4 AMA PRA Category I Credits™, this activity meets the CME requirements necessary for physicians to participate in the Massachusetts Medical Use of Marijuana Program.

    See full details chevron_right
    • Cost: $200
    • Credit hours: 4
    • CME credits awarded by: Global Education Group
    • Format: On Demand Online
    • Material last updated: 4/5/20
    • Expiration of CME credit: 4/4/21